Shepherd AF - Search Results

1

An ¹⁸F-FDG PET/CT and Mean Lung Dose Model to Predict Early Radiation Pneumonitis in Stage III Non-Small Cell Lung Cancer Patients Treated with Chemoradiation and Immunotherapy.

Thor M, Lee C, Sun L, Patel P, Apte A, Grkovski M, Shepherd AF, Gelblum DY, Wu AJ, Simone CB 2nd, Chaft JE, Rimner A, Gomez DR, Deasy JO, Shaverdian N. Thor M, et al. Among authors: shepherd af. J Nucl Med. 2024 Apr 1;65(4):520-526. doi: 10.2967/jnumed.123.266965. J Nucl Med. 2024. PMID: 38485270

2

Thymic Carcinoma Management Patterns among International Thymic Malignancy Interest Group (ITMIG) Physicians with Consensus from the Thymic Carcinoma Working Group.

Shepherd A, Riely G, Detterbeck F, Simone CB 2nd, Ahmad U, Huang J, Korst R, Rajan A, Rimner A. Shepherd A, et al. J Thorac Oncol. 2017 Apr;12(4):745-751. doi: 10.1016/j.jtho.2016.11.2219. Epub 2016 Nov 19. J Thorac Oncol. 2017. PMID: 27876674 Free PMC article.

3

Heart Dosimetry is Correlated With Risk of Radiation Pneumonitis After Lung-Sparing Hemithoracic Pleural Intensity Modulated Radiation Therapy for Malignant Pleural Mesothelioma.

Yorke ED, Jackson A, Kuo LC, Ojo A, Panchoo K, Adusumilli P, Zauderer MG, Rusch VW, Shepherd A, Rimner A. Yorke ED, et al. Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):61-69. doi: 10.1016/j.ijrobp.2017.04.025. Epub 2017 Apr 27. Int J Radiat Oncol Biol Phys. 2017. PMID: 28816162 Free PMC article.

4

Clinical evaluation of 4D MRI in the delineation of gross and internal tumor volumes in comparison with 4DCT.

Zhang J, Srivastava S, Wang C, Beckham T, Johnson C, Dutta P, Shepherd A, Mechalakos J, Hunt M, Wu A, Rimner A, Li G. Zhang J, et al. J Appl Clin Med Phys. 2019 Sep;20(9):51-60. doi: 10.1002/acm2.12699. J Appl Clin Med Phys. 2019. PMID: 31538719 Free PMC article.

5

Hypofractionated vs. conventional radiation therapy for stage III non-small cell lung cancer treated without chemotherapy.

Iocolano M, Wild AT, Hannum M, Zhang Z, Simone CB 2nd, Gelblum D, Wu AJ, Rimner A, Shepherd AF. Iocolano M, et al. Among authors: shepherd af. Acta Oncol. 2020 Feb;59(2):164-170. doi: 10.1080/0284186X.2019.1675907. Epub 2019 Oct 12. Acta Oncol. 2020. PMID: 31608751 Free PMC article.

6

Utilization and factors precluding the initiation of consolidative durvalumab in unresectable stage III non-small cell lung cancer.

Shaverdian N, Offin MD, Rimner A, Shepherd AF, Wu AJ, Rudin CM, Hellmann MD, Chaft JE, Gomez DR. Shaverdian N, et al. Among authors: shepherd af. Radiother Oncol. 2020 Mar;144:101-104. doi: 10.1016/j.radonc.2019.11.015. Epub 2019 Nov 28. Radiother Oncol. 2020. PMID: 31786421 Free PMC article.

7

Delivering safe and effective stereotactic body radiation therapy for patients with centrally located early stage non-small cell lung cancer.

Haseltine JM, Rimner A, Shepherd AF, Wu AJ, Gelblum DY, Shaverdian N, Gomez DR, Simone CB 2nd. Haseltine JM, et al. Among authors: shepherd af. Chin Clin Oncol. 2020 Jun;9(3):39. doi: 10.21037/cco.2019.12.17. Epub 2020 Jan 15. Chin Clin Oncol. 2020. PMID: 32008333 Free article. No abstract available.

8

Thoracic Radiation Therapy During Coronavirus Disease 2019: Provisional Guidelines from a Comprehensive Cancer Center within a Pandemic Epicenter.

Wu AJ, Rimner A, Shepherd AF, Gelblum DY, Shaverdian N, Yorke E, Simone CB 2nd, Gomez DR. Wu AJ, et al. Among authors: shepherd af. Adv Radiat Oncol. 2020 Apr 20;5(4):603-607. doi: 10.1016/j.adro.2020.04.008. eCollection 2020 Jul-Aug. Adv Radiat Oncol. 2020. PMID: 32318643 Free PMC article.

9

Clinical outcomes, local-regional control and the role for metastasis-directed therapies in stage III non-small cell lung cancers treated with chemoradiation and durvalumab.

Offin M, Shaverdian N, Rimner A, Lobaugh S, Shepherd AF, Simone CB 2nd, Gelblum DY, Wu AJ, Lee N, Kris MG, Rudin CM, Zhang Z, Hellmann MD, Chaft JE, Gomez DR. Offin M, et al. Among authors: shepherd af. Radiother Oncol. 2020 Aug;149:205-211. doi: 10.1016/j.radonc.2020.04.047. Epub 2020 Apr 30. Radiother Oncol. 2020. PMID: 32361014 Free PMC article.

10

Palliative Radiation Therapy for Oncologic Emergencies in the Setting of COVID-19: Approaches to Balancing Risks and Benefits.

Yerramilli D, Xu AJ, Gillespie EF, Shepherd AF, Beal K, Gomez D, Yamada J, Tsai CJ, Yang TJ. Yerramilli D, et al. Among authors: shepherd af. Adv Radiat Oncol. 2020 Apr 8;5(4):589-594. doi: 10.1016/j.adro.2020.04.001. eCollection 2020 Jul-Aug. Adv Radiat Oncol. 2020. PMID: 32363243 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page